Huma Qamar's most recent trade in Ocugen Inc was a trade of 1,145,468 Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ocugen Inc | Huma Qamar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,145,468 | 1,145,468 | - | - | Option (Right to Buy) | |
| Ocugen Inc | Huma Qamar | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2024 | 308,465 | 308,465 | - | - | Option (Right to Buy) |